COMPOSITIONS AND METHODS FOR ALTERING HUMAN CUTANEOUS MICROBIOME TO INCREASE GROWTH OF STAPHYLOCOCCUS EPIDERMIDIS AND REDUCE STAPHYLOCOCCUS AUREUS PROLIFERATION
An antibacterial composition comprising arginine bicarbonate, zinc carbonate, preferably arginine bicarbonate and zinc carbonate (ABZC), in combination, plus one or more physiologically acceptable excipients, administered for the modification of cutaneous microfloras, generally to inhibit the growth of pathogenic Staphylococcus aureus bacteria by promoting the growth of non-pathogenic Staphylococcus epidermidis bacteria.